Global Huntington's Disease Therapeutics Market Insights, Forecast to 2029

Global Huntington's Disease Therapeutics Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Huntington's Disease Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antidopaminergics
1.2.3 Anticonvulsants
1.2.4 Antipsychotics
1.2.5 Antidepressants
1.3 Market by Application
1.3.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Huntington's Disease Therapeutics Sales Estimates and Forecasts 2018-2029
2.2 Global Huntington's Disease Therapeutics Revenue by Region
2.2.1 Global Huntington's Disease Therapeutics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Huntington's Disease Therapeutics Revenue by Region (2018-2023)
2.2.3 Global Huntington's Disease Therapeutics Revenue by Region (2024-2029)
2.2.4 Global Huntington's Disease Therapeutics Revenue Market Share by Region (2018-2029)
2.3 Global Huntington's Disease Therapeutics Sales Estimates and Forecasts 2018-2029
2.4 Global Huntington's Disease Therapeutics Sales by Region
2.4.1 Global Huntington's Disease Therapeutics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Huntington's Disease Therapeutics Sales by Region (2018-2023)
2.4.3 Global Huntington's Disease Therapeutics Sales by Region (2024-2029)
2.4.4 Global Huntington's Disease Therapeutics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Huntington's Disease Therapeutics Sales by Manufacturers
3.1.1 Global Huntington's Disease Therapeutics Sales by Manufacturers (2018-2023)
3.1.2 Global Huntington's Disease Therapeutics Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Huntington's Disease Therapeutics in 2022
3.2 Global Huntington's Disease Therapeutics Revenue by Manufacturers
3.2.1 Global Huntington's Disease Therapeutics Revenue by Manufacturers (2018-2023)
3.2.2 Global Huntington's Disease Therapeutics Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Huntington's Disease Therapeutics Revenue in 2022
3.3 Global Key Players of Huntington's Disease Therapeutics, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Huntington's Disease Therapeutics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Huntington's Disease Therapeutics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Huntington's Disease Therapeutics, Product Offered and Application
3.8 Global Key Manufacturers of Huntington's Disease Therapeutics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Huntington's Disease Therapeutics Sales by Type
4.1.1 Global Huntington's Disease Therapeutics Historical Sales by Type (2018-2023)
4.1.2 Global Huntington's Disease Therapeutics Forecasted Sales by Type (2024-2029)
4.1.3 Global Huntington's Disease Therapeutics Sales Market Share by Type (2018-2029)
4.2 Global Huntington's Disease Therapeutics Revenue by Type
4.2.1 Global Huntington's Disease Therapeutics Historical Revenue by Type (2018-2023)
4.2.2 Global Huntington's Disease Therapeutics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Huntington's Disease Therapeutics Revenue Market Share by Type (2018-2029)
4.3 Global Huntington's Disease Therapeutics Price by Type
4.3.1 Global Huntington's Disease Therapeutics Price by Type (2018-2023)
4.3.2 Global Huntington's Disease Therapeutics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Huntington's Disease Therapeutics Sales by Application
5.1.1 Global Huntington's Disease Therapeutics Historical Sales by Application (2018-2023)
5.1.2 Global Huntington's Disease Therapeutics Forecasted Sales by Application (2024-2029)
5.1.3 Global Huntington's Disease Therapeutics Sales Market Share by Application (2018-2029)
5.2 Global Huntington's Disease Therapeutics Revenue by Application
5.2.1 Global Huntington's Disease Therapeutics Historical Revenue by Application (2018-2023)
5.2.2 Global Huntington's Disease Therapeutics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Huntington's Disease Therapeutics Revenue Market Share by Application (2018-2029)
5.3 Global Huntington's Disease Therapeutics Price by Application
5.3.1 Global Huntington's Disease Therapeutics Price by Application (2018-2023)
5.3.2 Global Huntington's Disease Therapeutics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Huntington's Disease Therapeutics Market Size by Type
6.1.1 US & Canada Huntington's Disease Therapeutics Sales by Type (2018-2029)
6.1.2 US & Canada Huntington's Disease Therapeutics Revenue by Type (2018-2029)
6.2 US & Canada Huntington's Disease Therapeutics Market Size by Application
6.2.1 US & Canada Huntington's Disease Therapeutics Sales by Application (2018-2029)
6.2.2 US & Canada Huntington's Disease Therapeutics Revenue by Application (2018-2029)
6.3 US & Canada Huntington's Disease Therapeutics Market Size by Country
6.3.1 US & Canada Huntington's Disease Therapeutics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Huntington's Disease Therapeutics Sales by Country (2018-2029)
6.3.3 US & Canada Huntington's Disease Therapeutics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Huntington's Disease Therapeutics Market Size by Type
7.1.1 Europe Huntington's Disease Therapeutics Sales by Type (2018-2029)
7.1.2 Europe Huntington's Disease Therapeutics Revenue by Type (2018-2029)
7.2 Europe Huntington's Disease Therapeutics Market Size by Application
7.2.1 Europe Huntington's Disease Therapeutics Sales by Application (2018-2029)
7.2.2 Europe Huntington's Disease Therapeutics Revenue by Application (2018-2029)
7.3 Europe Huntington's Disease Therapeutics Market Size by Country
7.3.1 Europe Huntington's Disease Therapeutics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Huntington's Disease Therapeutics Sales by Country (2018-2029)
7.3.3 Europe Huntington's Disease Therapeutics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Huntington's Disease Therapeutics Market Size
8.1.1 China Huntington's Disease Therapeutics Sales (2018-2029)
8.1.2 China Huntington's Disease Therapeutics Revenue (2018-2029)
8.2 China Huntington's Disease Therapeutics Market Size by Application
8.2.1 China Huntington's Disease Therapeutics Sales by Application (2018-2029)
8.2.2 China Huntington's Disease Therapeutics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Huntington's Disease Therapeutics Market Size by Type
9.1.1 Asia Huntington's Disease Therapeutics Sales by Type (2018-2029)
9.1.2 Asia Huntington's Disease Therapeutics Revenue by Type (2018-2029)
9.2 Asia Huntington's Disease Therapeutics Market Size by Application
9.2.1 Asia Huntington's Disease Therapeutics Sales by Application (2018-2029)
9.2.2 Asia Huntington's Disease Therapeutics Revenue by Application (2018-2029)
9.3 Asia Huntington's Disease Therapeutics Sales by Region
9.3.1 Asia Huntington's Disease Therapeutics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Huntington's Disease Therapeutics Revenue by Region (2018-2029)
9.3.3 Asia Huntington's Disease Therapeutics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Huntington's Disease Therapeutics Market Size by Type
10.1.1 Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Huntington's Disease Therapeutics Market Size by Application
10.2.1 Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Country
10.3.1 Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Information
11.2.2 H. Lundbeck Overview
11.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 H. Lundbeck Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 H. Lundbeck Recent Developments
11.3 Prana Biotechnology
11.3.1 Prana Biotechnology Company Information
11.3.2 Prana Biotechnology Overview
11.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Prana Biotechnology Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Prana Biotechnology Recent Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Information
11.4.2 Teva Pharmaceutical Industries Overview
11.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Pharmaceutical Industries Recent Developments
11.5 Horizon Pharma
11.5.1 Horizon Pharma Company Information
11.5.2 Horizon Pharma Overview
11.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Horizon Pharma Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Horizon Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Huntington's Disease Therapeutics Industry Chain Analysis
12.2 Huntington's Disease Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Huntington's Disease Therapeutics Production Mode & Process
12.4 Huntington's Disease Therapeutics Sales and Marketing
12.4.1 Huntington's Disease Therapeutics Sales Channels
12.4.2 Huntington's Disease Therapeutics Distributors
12.5 Huntington's Disease Therapeutics Customers
13 Market Dynamics
13.1 Huntington's Disease Therapeutics Industry Trends
13.2 Huntington's Disease Therapeutics Market Drivers
13.3 Huntington's Disease Therapeutics Market Challenges
13.4 Huntington's Disease Therapeutics Market Restraints
14 Key Findings in The Global Huntington's Disease Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Huntington's Disease Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Antidopaminergics
Table 3. Major Manufacturers of Anticonvulsants
Table 4. Major Manufacturers of Antipsychotics
Table 5. Major Manufacturers of Antidepressants
Table 6. Global Huntington's Disease Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Huntington's Disease Therapeutics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Huntington's Disease Therapeutics Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Huntington's Disease Therapeutics Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2018-2023)
Table 11. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2024-2029)
Table 12. Global Huntington's Disease Therapeutics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Huntington's Disease Therapeutics Sales by Region (2018-2023) & (K Units)
Table 14. Global Huntington's Disease Therapeutics Sales by Region (2024-2029) & (K Units)
Table 15. Global Huntington's Disease Therapeutics Sales Market Share by Region (2018-2023)
Table 16. Global Huntington's Disease Therapeutics Sales Market Share by Region (2024-2029)
Table 17. Global Huntington's Disease Therapeutics Sales by Manufacturers (2018-2023) & (K Units)
Table 18. Global Huntington's Disease Therapeutics Sales Share by Manufacturers (2018-2023)
Table 19. Global Huntington's Disease Therapeutics Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Huntington's Disease Therapeutics Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Huntington's Disease Therapeutics, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Huntington's Disease Therapeutics Price by Manufacturers 2018-2023 (USD/Unit)
Table 23. Global Huntington's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Huntington's Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington's Disease Therapeutics as of 2022)
Table 25. Global Key Manufacturers of Huntington's Disease Therapeutics, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Huntington's Disease Therapeutics, Product Offered and Application
Table 27. Global Key Manufacturers of Huntington's Disease Therapeutics, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Huntington's Disease Therapeutics Sales by Type (2018-2023) & (K Units)
Table 30. Global Huntington's Disease Therapeutics Sales by Type (2024-2029) & (K Units)
Table 31. Global Huntington's Disease Therapeutics Sales Share by Type (2018-2023)
Table 32. Global Huntington's Disease Therapeutics Sales Share by Type (2024-2029)
Table 33. Global Huntington's Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Huntington's Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Huntington's Disease Therapeutics Revenue Share by Type (2018-2023)
Table 36. Global Huntington's Disease Therapeutics Revenue Share by Type (2024-2029)
Table 37. Huntington's Disease Therapeutics Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Huntington's Disease Therapeutics Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Huntington's Disease Therapeutics Sales by Application (2018-2023) & (K Units)
Table 40. Global Huntington's Disease Therapeutics Sales by Application (2024-2029) & (K Units)
Table 41. Global Huntington's Disease Therapeutics Sales Share by Application (2018-2023)
Table 42. Global Huntington's Disease Therapeutics Sales Share by Application (2024-2029)
Table 43. Global Huntington's Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Huntington's Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Huntington's Disease Therapeutics Revenue Share by Application (2018-2023)
Table 46. Global Huntington's Disease Therapeutics Revenue Share by Application (2024-2029)
Table 47. Huntington's Disease Therapeutics Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Huntington's Disease Therapeutics Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Huntington's Disease Therapeutics Sales by Type (2018-2023) & (K Units)
Table 50. US & Canada Huntington's Disease Therapeutics Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Huntington's Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Huntington's Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Huntington's Disease Therapeutics Sales by Application (2018-2023) & (K Units)
Table 54. US & Canada Huntington's Disease Therapeutics Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Huntington's Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Huntington's Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Huntington's Disease Therapeutics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Huntington's Disease Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Huntington's Disease Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Huntington's Disease Therapeutics Sales by Country (2018-2023) & (K Units)
Table 61. US & Canada Huntington's Disease Therapeutics Sales by Country (2024-2029) & (K Units)
Table 62. Europe Huntington's Disease Therapeutics Sales by Type (2018-2023) & (K Units)
Table 63. Europe Huntington's Disease Therapeutics Sales by Type (2024-2029) & (K Units)
Table 64. Europe Huntington's Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Huntington's Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Huntington's Disease Therapeutics Sales by Application (2018-2023) & (K Units)
Table 67. Europe Huntington's Disease Therapeutics Sales by Application (2024-2029) & (K Units)
Table 68. Europe Huntington's Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Huntington's Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Huntington's Disease Therapeutics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Huntington's Disease Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Huntington's Disease Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Huntington's Disease Therapeutics Sales by Country (2018-2023) & (K Units)
Table 74. Europe Huntington's Disease Therapeutics Sales by Country (2024-2029) & (K Units)
Table 75. China Huntington's Disease Therapeutics Sales by Type (2018-2023) & (K Units)
Table 76. China Huntington's Disease Therapeutics Sales by Type (2024-2029) & (K Units)
Table 77. China Huntington's Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Huntington's Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Huntington's Disease Therapeutics Sales by Application (2018-2023) & (K Units)
Table 80. China Huntington's Disease Therapeutics Sales by Application (2024-2029) & (K Units)
Table 81. China Huntington's Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Huntington's Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Huntington's Disease Therapeutics Sales by Type (2018-2023) & (K Units)
Table 84. Asia Huntington's Disease Therapeutics Sales by Type (2024-2029) & (K Units)
Table 85. Asia Huntington's Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Huntington's Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Huntington's Disease Therapeutics Sales by Application (2018-2023) & (K Units)
Table 88. Asia Huntington's Disease Therapeutics Sales by Application (2024-2029) & (K Units)
Table 89. Asia Huntington's Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Huntington's Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Huntington's Disease Therapeutics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Huntington's Disease Therapeutics Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Huntington's Disease Therapeutics Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Huntington's Disease Therapeutics Sales by Region (2018-2023) & (K Units)
Table 95. Asia Huntington's Disease Therapeutics Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Type (2018-2023) & (K Units)
Table 97. Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Application (2018-2023) & (K Units)
Table 101. Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Country (2018-2023) & (K Units)
Table 108. Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales by Country (2024-2029) & (K Units)
Table 109. F. Hoffmann-La Roche Company Information
Table 110. F. Hoffmann-La Roche Description and Major Businesses
Table 111. F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. F. Hoffmann-La Roche Recent Developments
Table 114. H. Lundbeck Company Information
Table 115. H. Lundbeck Description and Major Businesses
Table 116. H. Lundbeck Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. H. Lundbeck Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. H. Lundbeck Recent Developments
Table 119. Prana Biotechnology Company Information
Table 120. Prana Biotechnology Description and Major Businesses
Table 121. Prana Biotechnology Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Prana Biotechnology Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Prana Biotechnology Recent Developments
Table 124. Teva Pharmaceutical Industries Company Information
Table 125. Teva Pharmaceutical Industries Description and Major Businesses
Table 126. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Teva Pharmaceutical Industries Recent Developments
Table 129. Horizon Pharma Company Information
Table 130. Horizon Pharma Description and Major Businesses
Table 131. Horizon Pharma Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Horizon Pharma Huntington's Disease Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Horizon Pharma Recent Developments
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Huntington's Disease Therapeutics Distributors List
Table 137. Huntington's Disease Therapeutics Customers List
Table 138. Huntington's Disease Therapeutics Market Trends
Table 139. Huntington's Disease Therapeutics Market Drivers
Table 140. Huntington's Disease Therapeutics Market Challenges
Table 141. Huntington's Disease Therapeutics Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington's Disease Therapeutics Product Picture
Figure 2. Global Huntington's Disease Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Huntington's Disease Therapeutics Market Share by Type in 2022 & 2029
Figure 4. Antidopaminergics Product Picture
Figure 5. Anticonvulsants Product Picture
Figure 6. Antipsychotics Product Picture
Figure 7. Antidepressants Product Picture
Figure 8. Global Huntington's Disease Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Huntington's Disease Therapeutics Market Share by Application in 2022 & 2029
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Diagnostic Centers
Figure 13. Huntington's Disease Therapeutics Report Years Considered
Figure 14. Global Huntington's Disease Therapeutics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Huntington's Disease Therapeutics Revenue 2018-2029 (US$ Million)
Figure 16. Global Huntington's Disease Therapeutics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2018-2029)
Figure 18. Global Huntington's Disease Therapeutics Sales 2018-2029 ((K Units)
Figure 19. Global Huntington's Disease Therapeutics Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Huntington's Disease Therapeutics Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Huntington's Disease Therapeutics Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Huntington's Disease Therapeutics Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Huntington's Disease Therapeutics Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Huntington's Disease Therapeutics Sales YoY (2018-2029) & (K Units)
Figure 25. China Huntington's Disease Therapeutics Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Huntington's Disease Therapeutics Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Huntington's Disease Therapeutics Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Huntington's Disease Therapeutics Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Huntington's Disease Therapeutics Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Huntington's Disease Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Huntington's Disease Therapeutics in the World: Market Share by Huntington's Disease Therapeutics Revenue in 2022
Figure 32. Global Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Huntington's Disease Therapeutics Sales Market Share by Type (2018-2029)
Figure 34. Global Huntington's Disease Therapeutics Revenue Market Share by Type (2018-2029)
Figure 35. Global Huntington's Disease Therapeutics Sales Market Share by Application (2018-2029)
Figure 36. Global Huntington's Disease Therapeutics Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Huntington's Disease Therapeutics Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Huntington's Disease Therapeutics Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Huntington's Disease Therapeutics Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Huntington's Disease Therapeutics Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Huntington's Disease Therapeutics Revenue Share by Country (2018-2029)
Figure 42. US & Canada Huntington's Disease Therapeutics Sales Share by Country (2018-2029)
Figure 43. U.S. Huntington's Disease Therapeutics Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Huntington's Disease Therapeutics Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Huntington's Disease Therapeutics Sales Market Share by Type (2018-2029)
Figure 46. Europe Huntington's Disease Therapeutics Revenue Market Share by Type (2018-2029)
Figure 47. Europe Huntington's Disease Therapeutics Sales Market Share by Application (2018-2029)
Figure 48. Europe Huntington's Disease Therapeutics Revenue Market Share by Application (2018-2029)
Figure 49. Europe Huntington's Disease Therapeutics Revenue Share by Country (2018-2029)
Figure 50. Europe Huntington's Disease Therapeutics Sales Share by Country (2018-2029)
Figure 51. Germany Huntington's Disease Therapeutics Revenue (2018-2029) & (US$ Million)
Figure 52. France Huntington's Disease Therapeutics Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Huntington's Disease Therapeutics Revenue (2018-2029) & (US$ Million)
Figure 54. Italy

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Huntington's Disease Therapeutics Market Insights, Forecast to 2029

Published: 30-May-2023        Price: US 4900 Onwards        Pages: 94

Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. The global Huntington's Disease Therapeutics market is projec......

Global Huntington's Disease Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 15-Mar-2023        Price: US 3280 Onwards        Pages: 105

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Huntington's Disease Therapeutics Market Research Report 2023, Forecast to 2028

Published: 15-Mar-2023        Price: US 2680 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Huntington's Disease Therapeutics Market Research Report 2023

Published: 07-Mar-2023        Price: US 2900 Onwards        Pages: 88

Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. Highlights The global Huntington's Disease Therapeutic......

Global Huntington's Disease Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published: 16-Nov-2022        Price: US 5600 Onwards        Pages: 103

Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Huntington's Disease Therapeutics manufacturers, distributors, end users, industry associations, governments' industry bure......

Global Huntington's Disease Therapeutics Market Research Report 2022

Published: 13-Jul-2022        Price: US 2900 Onwards        Pages: 90

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Antidopaminergics Anticonvulsants Antipsychotics Antidepressants Segment by Application......

Huntington's Disease Therapeutics Market - Global Outlook and Forecast 2021-2027

Published: 02-Nov-2021        Price: US 3250 Onwards        Pages: 91

This report contains market size and forecasts of Huntington's Disease Therapeutics in global, including the following market information: Global Huntington's Disease Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Huntington's Disease Therapeutics Market Sales, 2016-2021, 2022-2027, (K MT) Global top five Huntington's Disease Therapeutics companies in 2020 (%) The global Huntington's Disease Therapeutics market was valued at 233.9 million in 20......

Global and Japan Huntington's Disease Therapeutics Market Insights, Forecast to 2027

Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 138

Huntington's Disease Therapeutics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Huntington's Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focu......

Global Huntington's Disease Therapeutics Market Research Report 2021

Published: 11-Feb-2021        Price: US 2900 Onwards        Pages: 94

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Antidopaminergics - Anticonvulsants - Antipsychotics - Antidepressants Segment by App......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs